MicroPort Announces Strategic Investment in Fujian Co-ray Pharmaceutical

Gelonghui, September 12 | According to an announcement by MicroPort Scientific Corporation on the Hong Kong Stock Exchange, Shanghai MicroPort, as a strategic investor, will acquire a 45% equity stake in Fujian Kerui Pharmaceutical Co., Ltd. held by the transferors for approximately RMB 111 million. Upon completion of the transaction, Shanghai MicroPort will become the single largest shareholder of Kerui Pharmaceutical. Shanghai MicroPort will obtain control over the daily operations of Kerui Pharmaceutical through contractual arrangements.